These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25063261)

  • 1. Kentucky pharmacists' opinions of the potential reclassification of pseudoephedrine as a legend drug.
    Monson KE; Freeman PR; Goodin AJ; Talbert J; Blumenschein K
    J Am Pharm Assoc (2003); 2014; 54(4):397-405. PubMed ID: 25063261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating gabapentin as a drug of abuse: A survey study of Kentucky community pharmacists.
    Blackmer J; Lindahl E; Strahl A; Schadler A; Freeman PR
    J Am Pharm Assoc (2003); 2019; 59(3):379-382. PubMed ID: 30786971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists' role in harm reduction: a survey assessment of Kentucky community pharmacists' willingness to participate in syringe/needle exchange.
    Goodin A; Fallin-Bennett A; Green T; Freeman PR
    Harm Reduct J; 2018 Jan; 15(1):4. PubMed ID: 29370808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing community pharmacist engagement in a policing partnership strategy to reduce the illicit diversion of pseudoephedrine products.
    Webster JL
    Res Social Adm Pharm; 2013; 9(6):903-17. PubMed ID: 23548589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
    Xi X; Huang Y; Lu Q; Ung COL; Hu H
    Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.
    Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S
    J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kentucky pharmacists' opinions and practices related to the sale of cigarettes and alcohol in pharmacies.
    Kotecki JE; Fowler JB; German TC; Stephenson SL; Warnick T
    J Community Health; 2000 Aug; 25(4):343-55. PubMed ID: 10941697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes of Florida pharmacists toward implementing a state prescription drug monitoring program for controlled substances.
    Fass JA; Hardigan PC
    J Manag Care Pharm; 2011; 17(6):430-8. PubMed ID: 21787028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent community pharmacist interest in participating in community pharmacy research networks.
    Carr MB; Divine H; Hanna C; Freeman PR; Blumenschein K
    J Am Pharm Assoc (2003); 2011; 51(6):727-33. PubMed ID: 22068194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of why some community pharmacists do not provide 72-hour emergency prescription drugs to Medicaid patients when prior authorization is not available.
    Shepherd MD
    J Manag Care Pharm; 2013 Sep; 19(7):523-33. PubMed ID: 23964613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kentucky pharmacists' perceptions regarding provision of hormonal contraception.
    Miracle DK; Oh G; Singleton M; Kebodeaux CD; Fink JL; Freeman PR
    J Am Pharm Assoc (2003); 2021; 61(6):e42-e51. PubMed ID: 34366288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription drug monitoring program utilization in Kentucky community pharmacies.
    Wixson SE; Blumenschein K; Goodin AJ; Talbert J; Freeman PR
    Pharm Pract (Granada); 2015; 13(2):540. PubMed ID: 26131042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing community pharmacists' enrollment in a state prescription monitoring program.
    Ulbrich TR; Dula CA; Green CG; Porter K; Bennett MS
    J Am Pharm Assoc (2003); 2010; 50(5):588-94. PubMed ID: 20833616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of unmet demand for pharmacists: a survey of rural community pharmacies in Wisconsin.
    Gadkari AS; Mott DA; Kreling DH; Bonnarens JK
    J Am Pharm Assoc (2003); 2008; 48(5):598-609. PubMed ID: 18826899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cooperation according to French Law "hospital, patients, health and territories": Pharmacists' involvement in Aquitaine region].
    d'Elbée M; Baumevieille M; Dumartin C
    Rev Epidemiol Sante Publique; 2017 Jun; 65(3):231-239. PubMed ID: 28262371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing.
    Freeman PR; Goodin A; Troske S; Strahl A; Fallin A; Green TC
    J Am Pharm Assoc (2003); 2017; 57(2S):S28-S33. PubMed ID: 28139459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.